Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities
-
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
-
PyroGenesis Confirms Completion of Installation of 4.5 MW Plasma Torch System at U.S. Defense and Aeronautics Research Facility
-
Oceanic Iron Ore Corp. Begins Trading on OTCQX Best Market
-
Homes for Heroes Names Amit Kulkarni CEO
-
MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting
-
Templafy Report Finds 95% of Knowledge Workers Edit AI-Generated Documents Before They’re Business-Ready
-
AMC Theatres® Partners With Evite to Launch New Value-Priced Birthday Party Experience
-
Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement
-
Canadians Invited to “Carry the Weight” this October – For Kids Like Hamdiya
-
International Plus Confirms BEGO Certified Clinic Status for German Manufactured Implant Systems in Istanbul
-
Ovintiv Renews Annual Share Buy-Back Program
-
Wallbox and Enode Partner to Expand Smart Charging Connectivity
-
Fish Head Farms® and Advanced Turf Solutions Announce Exclusive U.S. Sales, Marketing and Distribution Partnership for FISH SH!T® in Golf Course, Lawn and Landscape, and Sports Field Markets
-
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
-
Fluor Corporation to Hold Third Quarter Earnings Conference Call
-
TransUnion Announces Earnings Release Date for Third Quarter 2026 Results
-
Miami International Holdings Announces Date of Third Quarter 2026 Earnings Release and Conference Call
-
National Fuel Gas Company Completes Acquisition of CenterPoint Energy's Ohio Natural Gas Utility
-
LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion
-
Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29
-
Ares Raises $4.2 Billion for Inaugural Global Structured Solutions Strategy
-
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
-
AIG Appoints Turab Hussain Chief Risk Officer
-
CenterPoint Energy completes sale of its Ohio natural gas business to National Fuel Gas Company for $2.62 billion
-
Avery Dennison to Webcast Third Quarter 2026 Earnings Conference Call
-
GFL Environmental Announces Appointment of Allen Gransch as Chief Operating Officer
-
Innovative Industrial Properties Announces Mezzanine Loan Commitment of $245 Million for Alewife Park
-
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
-
CMC Earns 2026 Great Place to Work Certification
-
Brown & Brown, Inc. announces 2026 third-quarter earnings release and conference call dates
-
National Fuel Gas Company Completes Acquisition of CenterPoint Energy's Ohio Natural Gas Utility
-
Manifests Ireland Grows Customs Operations from 20,000 to 2 Million Annual Declarations with Descartes Customs Compliance Solution
-
Brown & Brown, Inc. announces 2026 third-quarter earnings release and conference call dates
-
Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat – EASD2026
-
American Vanguard Corporation (AVD) Announces CFO Transition
-
ProVen Growth and Income VCT plc: Total Voting Rights
-
Crowell & Moring Elects New Chair
-
iSpring Launches WRO4000 Smart Whole-House Reverse Osmosis System With 4,000-Gallon Daily Capacity
-
ProVen VCT plc: Total Voting Rights
-
Accenture Reports Fourth-Quarter and Full-Year Fiscal 2026 Results
-
Huawei Launches the HUAWEI Mate 90 Series, Equipped with the Flagship Tau Chipset Across the Entire Series
-
Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock
-
Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock
-
NICE issues final draft guidance recommending ▼ Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales
-
Integrated Dermatology Promotes Nicholas Anguish to Chief Executive Officer
-
Hannan Extends Previsto Gold Breccia to 410 Metres, Open in All Directions
-
444+ Holders Already In: Why Apeing’s $0.0006 Presale Is Gaining Attention Among 10 Top Meme Coins in 2026
-
McCORMICK REPORTS SOLID THIRD QUARTER PERFORMANCE AND REAFFIRMS 2026 OUTLOOK
-
BlackRock Future Builders™ Expands Nationwide to Help Thousands of American Workers Access Skilled Trades Careers
